Remedy Pharmaceuticals Receives Financing from Broadview

February 10, 2014:  Broadview Ventures invests in novel stroke drug company Remedy Pharmaceuticals. Remedy Pharmaceuticals, Inc. today announced that it completed an equity financing from a new investor, Broadview Ventures, for an undisclosed amount. Funds will be used to accelerate Remedy’s GAMES-RP clinical trial of its central nervous system drug RP-1127.

 

Press Release